Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Irish Pharmaceutical Healthcare Association .
Filed returns
76
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Irish Pharmaceutical Healthcare Association | Health | EU Presidency Associated event with Commission VarHelyi on European Competitiveness and the role of Life Sciences and the Pharmaceutical Industry. (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2026 | Irish Pharmaceutical Healthcare Association | Health | Access to medicines in Ireland (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2026 | Irish Pharmaceutical Healthcare Association | Health | Number of Clinical Trials in Ireland (Public policy or programme) | 16 | On lobbying.ie |
| Jan–Apr 2026 | Irish Pharmaceutical Healthcare Association | Health | Moving Codeine containing OTC medicines from pharmacy only to prescription. (Public policy or programme) | 17 | On lobbying.ie |
| Sep–Dec 2025 | Irish Pharmaceutical Healthcare Association | Health | US-EU Trade Tariffs (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | Irish Pharmaceutical Healthcare Association | Health | Issues concerning the timely reimbursement of medicines in Ireland. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2025 | Irish Pharmaceutical Healthcare Association | Health | Moving Codeine containing OTC medicines from pharmacy only to prescription. (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland. (Legislation) | 10 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | US Tariffs and EU - Irish Response (Matters involving public funds) | 8 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | US Tariffs and EU - Irish Response (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland. (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2025 | Irish Pharmaceutical Healthcare Association | Health | (i) Proposed revision of EU General Pharmaceutical Legislation and Irish Government position on intellectual Property rights; (ii) Issues concerning the timely reimbursement of medicines in Ireland; (iii) Industry… (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | Irish Pharmaceutical Healthcare Association | Health | Issues concerning the timely reimbursement of medicines in Ireland. (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2025 | Irish Pharmaceutical Healthcare Association | Health | (i) Proposed revision of EU General Pharmaceutical Legislation and Irish Government position on intellectual Property rights; (ii) Issues concerning the timely reimbursement of medicines in Ireland; (iii) Industry… (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmaceutical Healthcare Association | Health | IPHA General Election Manifesto asks - (i) Faster Access to new Medicines and (ii) Increased number of Clinical Trials. (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmaceutical Healthcare Association | Health | Issues concerning the timely reimbursement of medicines in Ireland. (Public policy or programme) | 13 | On lobbying.ie |
| May–Aug 2024 | Irish Pharmaceutical Healthcare Association | Health | IPHA General Election Manifesto asks (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | General discussion on issues regarding the reimbursement of medicines in Ireland and the European Commission proposed revision of the EU General Pharmaceutical Legislation. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | (1) European Commission's proposed revision of EU Pharma Legislation and related matters, with particular attention to intellectual property rights provisions and competitiveness. (2) General discussion on issues… (Legislation) | 2 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | Raise awareness about the European Commission's revision of the EU Pharmaceutical Strategy and IPHA's key asks for the next European Parliament mandate. (Legislation) | 10 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | (1) Budget 2024 - the need for funding of new medicines. (2) Likely no provision for new developments funding to HSE for new medicines in Budget 2024. (3) Absence of funding for new medicines in Budget 2024. (4)… (Matters involving public funds) | 34 | On lobbying.ie |
| Sep–Dec 2023 | Irish Pharmaceutical Healthcare Association | Health | (1) Reimbursement process improvements under consideration in the Mazar's Working Group. (2) Delays within Medicines Reimbursement System. (3) Preparation for negotiation of a Framework Agreement in 2025. (4) Process… (Public policy or programme) | 16 | On lobbying.ie |
| Sep–Dec 2023 | Irish Pharmaceutical Healthcare Association | Health | Review of EU Council and Parliament process for proposed amendments to pharmaceutical legislation. (Legislation) | 2 | On lobbying.ie |
| May–Aug 2023 | Irish Pharmaceutical Healthcare Association | Health | Proposed EU Commission Pharmaceutical Legislation (Legislation) | 1 | On lobbying.ie |
| May–Aug 2023 | Irish Pharmaceutical Healthcare Association | Health | Orphan Drugs and Health (Pricing and Supply of Medical Goods (Amendment) Bill 2021 (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2022 | Irish Pharmaceutical Healthcare Association | Health | Request meeting on improved transparency in the context of Sinn Féin's Healthcare (Transparent Payments) Bill 2022. (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2022 | Irish Pharmaceutical Healthcare Association | Health | EU Policy matters and fast access for new and innovative medicines. (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2022 | Irish Pharmaceutical Healthcare Association | Health | Medicines innovation - Arrange meeting with LIF (Danish biopharmaceutical association) to discuss policy matters in relation to medicines innovation (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2022 | Irish Pharmaceutical Healthcare Association | Health | Gas supplies and pharmaceutical production. (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2022 | Irish Pharmaceutical Healthcare Association | Health | (i) EU Pharmaceutical Policy; (ii) EFPIA WAIT Indicator Survey - Access to new medicines; (iii) Access to Orphan Medicines; (iv) EU Pharmaceutical Strategy (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2021 | Irish Pharmaceutical Healthcare Association | Health | IPHA Code of Practice for the Pharmaceutical Industry - including ToV disclosures. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2021 | Irish Pharmaceutical Healthcare Association | Health | (i) WTO TRIPS Waiver of IP rights; (ii) Potential new supply agreement. (iii) Access to potential life sciences strategy. (Matters involving public funds) | 2 | On lobbying.ie |
| May–Aug 2021 | Irish Pharmaceutical Healthcare Association | Health | Access to new medicines & new supply agreement (Matters involving public funds) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Urging the Government to oppose a waiver of IP rights at the WTO (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Access to new medicines (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Extension of framework agreement on medicines. (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2020 | Irish Pharmaceutical Healthcare Association | Health | Establishment of National Medicines Agency (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2020 | Irish Pharmaceutical Healthcare Association | Health | Interaction between DPER and DoH/HSE on funding for new medicines (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2020 | Irish Pharmaceutical Healthcare Association | Health | Medicines Policy and Programme for Government (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2020 | Irish Pharmaceutical Healthcare Association | Health | Importance of a definitive and focused medicines policy, especially regarding access, in the Programme for Government (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2020 | Irish Pharmaceutical Healthcare Association | Health | Importance of medicines policy in General Election dialogue (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2019 | Irish Pharmaceutical Healthcare Association | Health | Report commissioned by Department of Health from Mazars on drug reimbursement system (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2019 | Irish Pharmaceutical Healthcare Association | Health | State spend on medicines in hospitals 2015 to 2018 (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | PwC report for EFPIA on value of pharmaceutical industry (Public policy or programme) | 11 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | Health Committee hearings on medicines (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | IPHA Manifesto for Better Health (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | Manifesto of the European Federation of Pharmaceutical Industries and Associations (EFPIA) for the European elections (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | IPHA policy document "Manifesto for Better Health" (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | Originator pharmaceutical industry's preparations for Brexit (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | Private members bill to amend Health Act and introduce a separate reimbursement process for orphan drugs (Legislation) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 76 | 100.0% |